FDA Grants Priority Review for Arikayce Inhaled Antibiotic for MAC
The FDA accepted Insmed's supplemental new drug application with Priority Review for Arikayce to treat Mycobacterium avium complex (MAC) lung disease.
Breaking News
🔥 TOP 5 STORIES
Hantavirus Outbreak Highlights Person-to-Person Transmission Risks
A recent cruise ship outbreak of the Andes strain underscores the potential for silent spread and severe respiratory complications in travel networks.
The Latest News Delivered Directly to Your Inbox!
Join our mailing list to receive the latest news, information, and updates on the Respiratory Health.RT: The Digital Edition
Medtech & Pharma Breakthroughs
Cardiovascular, Sleep Improvements Should Guide Obesity Pharmacotherapies
A new scientific statement from the Endocrine Society emphasizes health outcomes such as sleep apnea and heart disease over weight loss alone.
Combatting Infectious Diseases
COPD & Asthma Updates
COPD Origins Tied to Early Child Lung Development, Air Pollution
Children with an inherited risk for COPD show slower lung growth when exposed to higher levels of air pollution during early childhood.
